Status:
UNKNOWN
IPD Meta-analysis of De-escalation Treatment Strategy After PCI in ACS
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
St. Antonius Hospital
Ludwig-Maximilians - University of Munich
Conditions:
Acute Coronary Syndrome
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Brief Summary
We will perform a systemic review of previously published data and an updated patient-level meta-analysis of studies, including the most recent publications. PubMed, EMBASE, Cochrane Central Register ...
Detailed Description
This is an individual patient-level data meta-analysis (IPD Meta-analysis). This study population was incorporated from studies that were previoiusly published. We will perform a systemic review of p...
Eligibility Criteria
Inclusion
- This study is a meta-analysis of previously published studies. Therefore, the eligibility criteria may be diverse according to the individual studies.
- \--------------------------
- Subject must have clinical diagnosis of acute coronary syndrome
Exclusion
- The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Prasugrel, Ticagrelor
Key Trial Info
Start Date :
June 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT04848766
Start Date
June 7 2021
End Date
December 1 2021
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea